Literature DB >> 8571162

The social network of patients with schizoaffective disorder as compared to healthy individuals.

P Nettelbladt1, C Svensson, U Serin, A Ojehagen.   

Abstract

The social network was evaluated by means of the self-rating scale 'Interview Schedule for Social Interaction' (ISSI) and semi-structured interviews in married patients with a DSM-III diagnosis of schizoaffective disorder (N = 17, partners, N = 16), married patients with diabetes (N = 10, partners, N = 10) and in married healthy individuals (N = 8, partners, N = 8). The two latter groups were comparison control groups matched for sex and age to the patients with a schizoaffective disorder. The scores on the ISSI and its subscales for the groups were compatible to those found in other Swedish studies. Patients with a schizoaffective disorder both experienced that they had less access to (AVAT) and were less satisfied with their deep emotional relations (ADAT). The same patients had a higher level of neuroticism as compared to the rest. The patients with a schizoaffective disorder had less often than the patients with diabetes been informed about their disease. Moreover, the partners to the patients with a schizoaffective disorder had not been informed about the disease and experienced that they had fewer social contacts (AVSI). A challenge for the professional network in psychiatry is to improve the information and education to families in which one member is struck by a schizoaffective disorder.

Entities:  

Mesh:

Year:  1995        PMID: 8571162     DOI: 10.1016/0277-9536(94)00390-f

Source DB:  PubMed          Journal:  Soc Sci Med        ISSN: 0277-9536            Impact factor:   4.634


  2 in total

1.  Why having a mental illness is not like having diabetes.

Authors: 
Journal:  Schizophr Bull       Date:  2006-05-17       Impact factor: 9.306

2.  Background factors in patients with schizoaffective disorder as compared with patients with diabetes and healthy individuals.

Authors:  P Nettelbladt; C Svensson; U Serin
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  1996       Impact factor: 5.270

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.